|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0178602,
umls-concept:C0205474,
umls-concept:C0376358,
umls-concept:C0392752,
umls-concept:C0439810,
umls-concept:C0450363,
umls-concept:C0600521,
umls-concept:C0871261,
umls-concept:C1274040,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-10-18
|
|
pubmed:abstractText |
Since the introduction of 3-D conformal radiotherapy (CRT) doses of </= 70 Gy have been used in many European countries. In this analysis, the impact of a short-term neoadjuvant hormonal treatment in combination with CRT to a moderate dose level of 66 Gy was examined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0179-7158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
178
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
542-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12386785-Adenocarcinoma,
pubmed-meshheading:12386785-Aged,
pubmed-meshheading:12386785-Androgen Antagonists,
pubmed-meshheading:12386785-Antineoplastic Agents, Hormonal,
pubmed-meshheading:12386785-Combined Modality Therapy,
pubmed-meshheading:12386785-Follow-Up Studies,
pubmed-meshheading:12386785-Humans,
pubmed-meshheading:12386785-Imaging, Three-Dimensional,
pubmed-meshheading:12386785-Male,
pubmed-meshheading:12386785-Middle Aged,
pubmed-meshheading:12386785-Neoadjuvant Therapy,
pubmed-meshheading:12386785-Neoplasm Staging,
pubmed-meshheading:12386785-Prostate-Specific Antigen,
pubmed-meshheading:12386785-Prostatic Neoplasms,
pubmed-meshheading:12386785-Radiotherapy, Computer-Assisted,
pubmed-meshheading:12386785-Radiotherapy, Conformal,
pubmed-meshheading:12386785-Radiotherapy Dosage,
pubmed-meshheading:12386785-Tumor Markers, Biological
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
|
|
pubmed:affiliation |
Department of Radiotherapy, University of Vienna, Austria. stefan.wachter@akh-wien.ac.at
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
